HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Show more...
FAQ
HAVN Life Sciences 今天的股價是多少?▼
5NP0.MU 目前價格為 €0.02 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 HAVN Life Sciences 股價表現。
HAVN Life Sciences 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Muenchen 交易所,HAVN Life Sciences 的股票以代號 5NP0.MU 進行交易。
HAVN Life Sciences 的市值是多少?▼
今天 HAVN Life Sciences 的市值為 280,022
HAVN Life Sciences 去年的營收是多少?▼
HAVN Life Sciences 去年的營收為 202,451.43EUR。
HAVN Life Sciences 去年的淨利是多少?▼
5NP0.MU 去年的淨收益為 -16.14MEUR。
HAVN Life Sciences 有多少名員工?▼
截至 July 26, 2026,公司共有 6 名員工。
HAVN Life Sciences 位於哪個產業?▼
HAVN Life Sciences從事於Health & Wellness產業。
HAVN Life Sciences 何時完成拆股?▼
HAVN Life Sciences 上次拆股發生於 August 03, 2022,比例為 1:30。
HAVN Life Sciences 的總部在哪裡?▼
HAVN Life Sciences 的總部位於 加拿大 的 Port Moody。